|
Video: What is a Stock Split?
|
|
Ginkgo Bioworks Holdings develops a platform for programming cells to enable customers to utilize biology to create products across various industries. Co.'s platform includes equipment, robotic automation, software, data pipelines and tools, and operating procedures for throughput genetic engineering, fermentation, and analytics (referred to collectively as the Foundry); and a library of proprietary genetic assets and associated performance data (referred to collectively as Codebase). According to our DNA split history records, Ginkgo Bioworks Holdings has had 3 splits. | |
|
Ginkgo Bioworks Holdings (DNA) has 3 splits in our DNA split history database. The first split for DNA took place on November 03, 1999. This was a 2 for 1
split, meaning for each share of DNA owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. DNA's second split took place on October 25, 2000. This was a 2 for 1 split, meaning for each share of DNA owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split. DNA's third split took place on May 13, 2004. This was a 2 for 1 split, meaning for each share of DNA owned pre-split, the shareholder now owned 2 shares. For example, a 4000 share position pre-split, became a 8000 share position following the split.
When a company such as Ginkgo Bioworks Holdings splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the DNA split history from start to finish, an original position size of 1000 shares would have turned into 8000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ginkgo Bioworks Holdings shares, starting with a $10,000 purchase of DNA, presented on a split-history-adjusted basis factoring in the complete DNA split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/20/2021 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$10.15 |
|
End price/share: |
$0.78 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-92.33% |
|
Average Annual Total Return: |
-57.32% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$766.65 |
|
Years: |
3.02 |
|
|
|
Date |
Ratio |
11/03/1999 | 2 for 1
| 10/25/2000 | 2 for 1 | 05/13/2004 | 2 for 1 |
|
|